JBIO

Jade Biosciences

80 hedge funds and large institutions have $45.1M invested in Jade Biosciences in 2024 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 28 increasing their positions, 10 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

0.22% less ownership

Funds ownership: 2.92%2.69% (-0.22%)

95% less capital invested

Capital invested by funds: $841M → $45.1M (-$796M)

100% less funds holding in top 10

Funds holding in top 10: 60 (-6)

Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$516K
Puts
$275K
Net Calls
Net Calls Change

Top Buyers

1 +$2.34M
2 +$1.54M
3 +$1.34M
4
Millennium Management
Millennium Management
New York
+$962K
5
OM
Opaleye Management
Massachusetts
+$730K

Top Sellers

1 -$35.6M
2 -$31.6M
3 -$26.2M
4
DCM
Driehaus Capital Management
Illinois
-$23.5M
5
O
OrbiMed
New York
-$16.7M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$15.3M
2
$6.24M
3
$3.72M
4
$2.99M
5
$2.34M
6
$1.83M
7
$1.63M
8
$1.34M
9
$1.07M
10
$1.04M
11
$773K
12
$730K
13
$611K
14
$566K
15
$527K
16
$463K
17
$413K
18
$410K
19
$332K
20
$298K
21
$210K
22
$183K
23
$183K
24
$159K
25
$151K